The treatment of MCL cell lines with ARV-771 and ARV-825 resulted in significant depletion of BRD4 and BRD2, in contrast to sole inhibition with OTX015, which led to an accumulation of BRD4 protein. The gene discussed is BRD4; the disease is mantle cell lymphoma.